Accelerated access review: final report
This report sets out recommendations on how patients could get quicker access to innovative new diagnostic tools, treatments, and medical technologies. It argues that streamlined processes could bring forward patient access to drugs by up to four years and patients will benefit from quicker access to medical technologies too. The report will help the NHS to provide the best care to patients, use funds more effectively, and create the conditions to help the life sciences industry continue to thrive.
No comments:
Post a Comment